
Diabetic retinopathy (DR) is a leading cause of vision loss, demanding early detection and intervention. This session will introduce the Aurora AEYE, a groundbreaking AI-powered handheld fundus camera designed to transform point-of-care DR screening. Discover how this innovative device enables rapid, accurate, and accessible fundus imaging, facilitating early diagnosis and treatment. Learn how the Aurora AEYE’s AI capabilities empower healthcare providers with instant insights to improve patient outcomes and revolutionize DR management. Join us to explore the future of eye care and the transformative impact of the Aurora AEYE. Key topics: 1. Addressing the challenges of DR screening 2. The power of AI in image analysis and diagnosis 3. Real-world implementation and clinical outcomes 4. Improving patient care and healthcare systems with the Aurora AEYE • Jeffry Gerson, O.D., F.A.A.O., Grin Eye Care & Macular Degeneration Assoc. Medical Director, Optomed USA, Inc